1. Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium
   Julia Sánchez-Ceinos et al, 2024, Cardiovascular Diabetology CrossRef
2. Emerging role of EZH2 in rheumatic diseases: A comprehensive review
   Wang‐Dong Xu et al, 2022, International Journal of Rheumatic Diseases CrossRef
3. Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
   Qiu Jun et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
4. The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
   Zihan Zhao et al, 2023, Frontiers in Immunology CrossRef
5. Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis
   Eko Fuji Ariyanto et al, 2024, Diabetes, Metabolic Syndrome and Obesity CrossRef
6. The Combined Effects of Material Surface Chemistry and Vitamin D3 on MC3T3-E1 Cells
   Yan Li et al, 2023, Journal of Biomaterials and Tissue Engineering CrossRef
7. Novel insights into the dynamic function of PRC2 in innate immunity
   Rosalie W.M. Kempkes et al, 2024, Trends in Immunology CrossRef
8. Interplay between epigenetic mechanisms and transcription factors in atherosclerosis
   Misbah Aziz et al, 2024, Atherosclerosis CrossRef
9. EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction
   Li Sun et al, 2023, Biochemical Pharmacology CrossRef
10. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
    Roxana Mihaela Chiorescu et al, 2022, International Journal of Molecular Sciences CrossRef